Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5 results about "Vaginal disease" patented technology

A vaginal disease is a pathological condition that affects part or all of the vagina.

A vaginal drug delivery device to improve the efficacy of drug delivery through the vagina

Disclosed herein are compositions and methods of manufacturing, testing, and using a biocompatible and disposable vaginal suppository, comprising chitosan, collagen, carboxymethyl cellulose, and an enzyme, capable of breaking down vaginal mucous and releasing the active ingredients consistently over extended periods of time. Methods disclosed herein may also include the use of these compositions, methods, and devices for treating vaginal diseases, such as vaginitis, genitourinary syndrome, and other conditions, such as vulvar and vaginal cancer, or cervical cancer.
Owner:VAGISTEM BIOTHERAPEUTICS INC

Probiotic-containing composition for inhibiting private pathogenic bacteria as well as preparation method and application of probiotic-containing composition

The invention relates to the technical field of daily chemical products, in particular to a probiotic-containing private pathogenic bacterium inhibiting composition and a preparation method and application thereof. The composition is formed by compounding a probiotic composition, a plant extract composition and silver ions or colloidal silver, the probiotic composition comprises the following components: corn starch, mannitol, microcrystalline cellulose, cane sugar, hydroxypropyl methyl cellulose, tocopheryl acetate, melaleuca alternifolia leaf oil and lactobacillus. The plant extract comprises a plant extract 1 and a plant extract 2, and the plant extract 1 comprises the following components: a radix sophorae flavescentis extract, a fructus cnidii extract, a cortex phellodendri extract, an artemisia capillaris extract, a matricaria recutita extract and a snow lotus herb extract; the plant extract 2 comprises the following components: a clove bud extract, litsea cubeba fruit oil, a thyme extract and a radix sophorae flavescentis extract, the growth of vaginal pathogenic bacteria at private parts is inhibited, meanwhile, the influence on beneficial bacteria in the vagina is reduced, the micro-ecological balance of the vagina is maintained, and the effect of preventing vaginal diseases is achieved.
Owner:HAINA SHANGPIN (SHENZHEN) INT TRADE CO LTD

Cleansing agent to prevent vaginal candidiasis

To provide a cleansing agent effective in the prevention and recurrence of vaginal diseases caused by Candida albicans, which has a strong bactericidal effect against Candida albicans and has little effect on other normal flora and can be suitably used by pregnant women.SOLUTION: Provided is a cleaning agent comprising a saponin derived from Holothuroidea, water as a base solvent, and a surfactant, a content of a holotoxin group in the saponin relative to the cleaning agent being 25 ppm or more, and the surfactant including a lauric acid-based surfactant which is a derivative of lauric acid, but not including an oleic acid-based surfactant which is a derivative of oleic acid.SELECTED DRAWING: Figure 1
Owner:TAKAKURA NEW IND CO LTD

Buffer composition for reducing aggregation

To provide a composition for nucleic acid-based detection and identification of vaginal diseases, e.g., vulvovaginal candidiasis, trichomoniasis and / or bacterial vaginosis.SOLUTION: A buffer composition is provided comprising a bactericidal preservative comprising a conjugate pair of an acid and a base, a chelating agent or reducing agent, a non-ionic surfactant, a monovalent or divalent salt selected from the group consisting of sodium salts, potassium salts, calcium salts, magnesium salts, and combinations thereof, and optionally one or more isothiazolones.SELECTED DRAWING: Figure 5
Owner:BECTON DICKINSON & CO

Internal medication device for gynecological vaginal disease examination

The invention provides an internal medication device for gynecological vaginal disease examination, and relates to the field of medical instruments. The internal medication device for gynecological vaginal disease examination comprises arc-shaped vaginal dilators and connectors, the connectors are arranged at one ends of the arc-shaped vaginal dilators, the number of the connectors and the number of the arc-shaped vaginal dilators are both two, the connectors and the arc-shaped vaginal dilators correspond to each other up and down, fixing blocks are fixedly connected to the middles of the two sides of the connectors, and the arc-shaped vaginal dilators correspond to the fixing blocks. A sliding rod penetrates through the interior of the fixing block on one side, a two-way screw rod is in threaded connection with the interior of the fixing block on the other side, first fixing plates are fixedly connected to the two ends of the sliding rod, and the two ends of the two-way screw rod are rotationally matched with the first fixing plates. The distance between the connector and the arc-shaped vaginal dilator is freely adjusted through rotation of the two-way screw rod, firstly, lubricating oil can be injected into the injection hole, the hose is connected with the arc-shaped vaginal dilator, liquid is discharged outwards through the rotary knob, and the effect of lubricating the outer wall of the arc-shaped vaginal dilator is achieved.
Owner:CHINESE PEOPLES LIBERATION ARMY GENERAL HOSPITAL HAINAN HOSPITAL